Investigating the association of vitamin D seasonality on inflammatory and hemostatic markers

Chronobiology International

Volumn 30, Issue 6, 2013, Pages 786-795

  Berry, Diane J ^a   Hyppönen, Elina ^a   Cortina Borja, Mario ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

25(OH)D; Bayesian analysis; Harmonic function; Hemostatic; Inflammation; Mediation analysis; Product of coefficients test; Seasonal variations

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; FIBRINOGEN; TISSUE PLASMINOGEN ACTIVATOR; VITAMIN D; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BAYES THEOREM; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HEMOSTASIS; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; OBESITY; SEASON; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ADULT; BAYES THEOREM; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEALTH STATUS; HEMOSTASIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MODELS, STATISTICAL; OBESITY; SEASONS; TISSUE PLASMINOGEN ACTIVATOR; VITAMIN D; VON WILLEBRAND FACTOR;

EID: 84879396369     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2013.765888     Document Type: Article

References (47)

1. Baron RM, Kenny DA. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol, 51, 1173-82.
2. Cannell JJ, Vieth R, Umhau JC, et al. (2006). Epidemic influenza and vitamin D. Epidemiol Infect, 134, 1129-40. (Pubitemid 44614932)
3. Cheng S, Massaro JM, Fox CS, et al. (2010). Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study. Diabetes, 59, 242-8.
4. Crawford VL, Sweeney O, Coyle PV, et al. (2000). The relationship between elevated fibrinogen and markers of infection: A comparison of seasonal cycles. QJM, 93, 745-50.
5. Crawford VL, McNerlan SE, Stout RW. (2003). Seasonal changes in platelets, fibrinogen and factor VII in elderly people. Age Ageing, 32, 661-5. (Pubitemid 37461576)
6. Fuller E, Power C, Shepherd P, Strachan DP. (2006). Technical report on the National Child Development Study biomedical survey 2002-2004. National Centre for Social Research, 33. http://www.cls.ioe.ac.uk/page.aspx? &sitesectionid=782& sitesectiontitle=Technical+Report. Last accessed date 4 June 2013.
7. Goldstein H (2010). Review of Winbugs. http://www.bristol.ac.uk/cmm/ learning/mmsoftware/reviewwinbugs.pdf [last accessed 20 Dec 2012].
8. Grimes DS, Hindle E, Dyer T. (1996). Sunlight, cholesterol and coronary heart disease. QJM, 89, 579-89. (Pubitemid 26278869)
9. Haddad Jr. JG, Hahn TJ. (1973). Natural and synthetic sources of circulating 25-hydroxyvitamin D in man. Nature, 244, 515-17.
10. Holick MF. (1995). Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr, 61, 638S-45S.
11. Horst R, Reinhardt T, Satyanarayana Reddy G. (2005). Vitamin D metabolism. In: Feldman D, Glorieux FH, Pike JW, eds. Vitamin D. 2nd ed. Amsterdam: Elsevier Academic Press, 15-36.
12. Hyppönen E, Power C. (2006). Vitamin D status and glucose homeostasis in the 1958 British birth cohort: The role of obesity. Diabetes Care, 29, 2244-6. (Pubitemid 44899859)
13. Hyppönen E, Power C. (2007). Hypovitaminosis D in British adults at age 45 y: Nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr, 85, 860-8. (Pubitemid 46393520)
14. Hyppönen E, Turner S, Cumberland P, et al. (2007). Serum 25-hydroxyvitamin D measurement in a large population survey with statistical harmonization of assay variation to an international standard. J Clin Endocrinol Metab, 92, 4615-22. (Pubitemid 350223435)
15. Hyppönen E, Berry D, Cortina-Borja M, Power C. (2010). 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: A cross sectional analysis in the 1958 British Birth Cohort. PLoS ONE, 5, e10801.
16. Judd CM, Kenny DA. (1981). Process analysis - estimating mediation in treatment evaluations. Eval Rev, 5, 602-19.
17. Kuha J. (2004). AIC and BIC - comparisons of assumptions and performance. Sociol Methods Res, 33, 188-229. (Pubitemid 39519122)
18. Lindqvist PG, Epstein E, Olsson H. (2009). Does an active sun exposure habit lower the risk of venous thrombotic events? A Dlightful hypothesis. J Thromb Haemost, 7, 605-10.
19. Lowe GD. (1997). Haemostatic risk factors for arterial and venous thrombosis. In: Poller L, Ludham CA, eds. Recent advances in blood coagulation. 7th ed. Publisher's location is London, UK: Churchill Livingstone, 69-96.
20. Lowe GD, Danesh J, Lewington S, et al. (2004). Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J, 25, 252-9. (Pubitemid 38235163)
21. Lunn DJ, Thomas A, Best N, Spiegelhalter D. (2000). WinBUGS - a Bayesian modelling framework: Concepts, structure, and extensibility. Stat Comput, 10, 325-37.
22. Mackinnon DP, Warsi G, Dwyer JH. (1995). A simulation study of mediated effect measures. Multivar Behav Res, 30, 41-62.
23. Mackinnon DP, Lockwood CM, Hoffman JM, et al. (2002). A comparison of methods to test mediation and other intervening variable effects. Psychol Methods, 7, 83-104.
24. Mackinnon DP, Fairchild AJ, Fritz MS. (2007). Mediation analysis. Annu Rev Psychol, 58, 593-614.
25. Ni MC, Rodgers A, Pan WH, et al. (2004). Body mass index and cardiovascular disease in the Asia-Pacific Region: An overview of 33 cohorts involving 310 000 participants. Int J Epidemiol, 33, 751-8. (Pubitemid 39263851)
26. Norman AW, Bouillon R. (2010). Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood), 235, 1034-45.
27. Parsons TJ, Thomas C, Power C. (2009). Estimated activity patterns in British 45 year olds: Cross-sectional findings from the 1958 British birth cohort. Eur J Clin Nutr, 63, 978-85.
28. Pike JW, Shevde NK. (2005). The vitamin D receptor. In: Feldman D, Glorieux FH, Pike JW, eds. Vitamin D. 2nd ed. Amsterdam: Elsevier Academic Press, 167-92.
29. Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int, 27, 1911-29.
30. Power C, Elliott J. (2006). Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol, 35, 34-41. (Pubitemid 43205440)
31. Refinetti R, Cornelissen G, Halberg F. (2007). Procedures for numerical analysis of circadian rhythms. Biol Rhythm Res, 38, 275-325. (Pubitemid 47039110)
32. Ridker PM. (2003). Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 107, 363-9. (Pubitemid 36158034)
33. Rudnicka AR, Rumley A, Lowe GD, Strachan DP. (2007). Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation, 115, 996-1003. (Pubitemid 46328293)
34. Scragg R. (1981). Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol, 10, 337-41. (Pubitemid 12164635)
35. Sobel ME. (1982). Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodol, 13, 290-312.
36. Spiegelhalter DJ, Best NG, Carlin BR, van der Linde A. (2002). Bayesian measures of model complexity and fit. J R Stat Soc B Stat Method, 64, 583-616.
37. StataCorp. (2009). Stata Statistical Software, Release 11 [computer software]. College Station, TX: StataCorp.
38. Swales HH, Wang TJ. (2010). Vitamin D and cardiovascular disease risk: Emerging evidence. Curr Opin Cardiol, 25, 513-17.
39. Tong YL. (1976). Parameter estimation in studying circadian rhythms. Biometrics, 32, 85-94.
40. Vonesh EF, Chinchilli VM. (1997). Linear and nonlinear models for the analysis of repeated measurements. New York: Marcel Dekker.
41. Wallis DE, Penckofer S, Sizemore GW. (2008). The ''sunshine deficit'' and cardiovascular disease. Circulation, 118, 1476-85.
42. Wassernam RH. (2005). Vitamin D and the intestinal absorption of calcuim: A view and overview. In: Feldman D, Glorieux FH, Pike JW, eds. Vitamin D. 2nd ed. Amsterdam: Elsevier Academic Press, 411-28.
43. Webb AR. (2006). Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol, 92, 17-25. (Pubitemid 43831964)
44. Webb AR, Kline L, Holick MF. (1988). Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab, 67, 373-8.
45. Webb AR, Kift R, Durkin MT, et al. (2010). The role of sunlight exposure in determining the vitamin D status of the U.K. white adult population. Br J Dermatol, 163, 1050-5.
46. Woodhouse PR, Khaw KT, Plummer M, et al. (1994). Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: Winter infections and death from cardiovascular disease. Lancet, 343, 435-9. (Pubitemid 24059584)
47. Zittermann A, Schleithoff SS, Koerfer R. (2005). Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr, 94, 483-92. (Pubitemid 41555486)